Here, we for the first time demonstrated combinative treatment of β-elemene and cetuximab induced ferroptotic cell death in KRAS mutant CRC cell HCT116, accompanied with decreased cell viability and increased iron-dependent accumulation of lipid peroxidation in these cancer cells. Here, KRAS is linked to cancer.